These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10874525)

  • 1. Thrombolytic therapy in acute myocardial infarction.
    Priglinger U; Huber K
    Drugs Aging; 2000 Apr; 16(4):301-12. PubMed ID: 10874525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic therapy for acute myocardial infarction.
    Meister FL; Stringer KA; Spinler SA; Gonzalez E; Talbert RL; Weiner B; Guerrero RM; Smith R
    Pharmacotherapy; 1998; 18(4):686-98. PubMed ID: 9692643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality reperfusion therapy for acute myocardial infarction.
    Cannon CP
    Am Heart J; 2000 Nov; 140(5):707-16. PubMed ID: 11054614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myocardial infarction: treatment with thrombolytic therapy.
    Topol EJ
    Cardiol Clin; 1989 Nov; 7(4):827-36. PubMed ID: 2688884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNK-tPA for acute myocardial infarction: the clinical experience.
    Pislaru SV; Van de Werf F
    Thromb Haemost; 1999 Sep; 82 Suppl 1():117-20. PubMed ID: 10695500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of survival using anistreplase (Eminase)].
    Murray RG
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():37-40. PubMed ID: 2108645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin-selective thrombolytic therapy with recombinant staphylokinase.
    Collen D; Vanderschueren S; Van de Werf F
    Haemostasis; 1996 Oct; 26 Suppl 4():294-300. PubMed ID: 8979135
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinolysis as a therapeutic option in acute ST-elevation myocardial infarction].
    Arntz HR; Mochmann HC
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2372-4. PubMed ID: 21082532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolytic therapy in acute myocardial infarct].
    Tullio D; Valerio A
    Clin Ter; 1992 May; 140(5):447-59. PubMed ID: 1424486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarifying the conundrum of conjunctive anticoagulation and coronary thrombolysis.
    Sobel BE
    Coron Artery Dis; 1995 Jan; 6(1):83-6. PubMed ID: 7767507
    [No Abstract]   [Full Text] [Related]  

  • 12. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL
    Rev Esp Cardiol; 1992; 45 Suppl 2():9-20. PubMed ID: 1475514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial.
    Sabatine MS; McCabe CH; Gibson CM; Cannon CP
    Am Heart J; 2005 Feb; 149(2):227-33. PubMed ID: 15846259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the long term effects of thrombolytic agents.
    van Domburg RT; Boersma E; Simoons ML
    Drugs; 2000 Aug; 60(2):293-305. PubMed ID: 10983734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results].
    Slama M; Cohen-Solal A; Spriet A
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():27-33. PubMed ID: 2512885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarction in the elderly: benefits and risks of thrombolytics.
    Aronow WS
    Drug Saf; 2002; 25(11):753-8. PubMed ID: 12222987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of thrombolytic therapy in acute myocardial infarction.
    Bradbury M; Cruickshank JP
    Br J Nurs; 1993 Jun 24-Jul 7; 2(12):619-24. PubMed ID: 8348005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.